Writer choice

36218For this Discussion, review the media titled “Attention-Deficit/Hyperactivity Disorder Counseling Session” and consider the medications a psychiatrist might prescribe to treat ADHD. Conduct an Internet search or a Walden Library search for at least one peer-reviewed journal article that addresses issues related to the use of stimulants for the treatment of ADHD as it relates to the client in the media program.

By Day 3

Post a brief description of the client’s current presentation in the media program. Choose a medication that a psychiatrist might prescribe to treat ADHD and explain in detail the major action, intended effects, neurotransmitters implicated in its use, and side effects. Explain why you think this medication might be the most effective for treatment. Explain how you might address any issues related to the use of stimulants for the treatment of ADHD. Justify your choice based on the client’s presentation and support your position with the Learning Resources and your journal article. Explain an alternative approach to treating ADHD

Required Readings

Lichtblau, L. (2011). Psychopharmacology demystified. Clifton Park, NY: Delmar, Cengage Learning.

•Chapter 5, “Cognitive Enhancers” (pp. 65–74)

Preston, J. D., O’Neal, J. H., & Talaga, M. C. (2017). Handbook of clinical psychopharmacology for therapists (8th ed.). Oakland, CA: New Harbinger.

•Chapter 23, “Child and Adolescent Psychopharmacology” (pp. 255-276)

Berman, S. M., Kuczenski, R., McCracken, J. T., & London, E. D. (2009). Potential adverse effects of amphetamine treatment on brain and behavior: A review. Molecular Psychiatry, 14(2), 123–142.

American Psychiatric Association (2013). Diagnostic and statistical manual of mental disorders (5th ed.). Arlington, VA: American Psychiatric Publishing. Retrieved from http://psychiatryonline.org.ezp.waldenulibrary.org/index.aspx
Use the DSM-5 to guide you through your understanding of the diagnostic criteria for mental disorders.

Pliszka, S. R. (2007). Pharmacologic treatment of attention-deficit/hyperactivity disorder: Efficacy, safety and mechanisms of action. Neuropsychology Review, 17(1), 61–72.